|
Media Coverage
Vaxin begins pandemic flu study using Birmingham volunteers - October 8, 2008
The Birmingham News
Vaxin developing game-changing flu vaccine
- August 26, 2008
TechJournal South
Biotech firm Vaxin taps new CEO, looks for VC funds - August 8, 2008
Birmingham Business Journal
E. coli-Vectored Tetanus and Anthrax Vaccine Patch Protective in Mice - July 4,2006
Link to
article
Vaxin executives eye Taiwan for money, location incentives - February 17, 2006
Link to article
(Taiwan) Vaxin's approach a 'new vision' for the vaccine industry: CEO (Taiwan Life Sciences Weekly - January 16, 2006
Link to article
Vaxin’s technology at the forefront of national development trends for 2004 - January 11, 2005
Link to article
New targets for anthrax remedies (SeparationsNOW.com)-December 2004
Link to article
Federal Funding is Key to vaccine producer Vaxin (Birmingham Business Journal) -Oct. 22, 2004
Link to article
NurseZone-carries information on Vaxin Research for medical professionals 11/12/01
Link to article
University of Alabama, Birmingham
http://www.uab.edu
FUTURE HEALTH & BIOLOGY TRENDS
(see October 2000)
Link to article
Press Releases
VAXIN RECEIVES $1.4 MILLION FOR ANTHRAX VACCINE DEVELOPMENT- December 10, 2008
Press Release
VAXIN AND CRUCELL ANNOUNCE COLLABORATION TO FIGHT ALZHEIMER’S DISEASE- November 13, 2008
Press Release
VAXIN TO PRESENT AT THE RODMAN & RENSHAW 1OTH ANNUAL
HEALTHCARE CONFERENCE - November 5, 2008
Press Release
VAXIN INITIATES PHASE I HUMAN STUDY OF H5N1 PANDEMIC FLU VACCINE - October 8, 2008
Press Release
VAXIN RECEIVES $100,000 GRANT FOR DEVELOPMENT OF ACNE VACCINE- September 18, 2008
Press Release
VAXIN AWARDED NIH FUNDING FOR AVIAN FLU VACCINE DEVELOPMENT- September 10, 2008
Press Release
VAXIN’S PANDEMIC VACCINE SPOTLIGHTED- August 13, 2008
Promising data presented at Immunotherapeutics & Vaccine Summit
Press Release
Vaxin Welcomes New CEO- August 8, 2008
New Leader To Advance Company’s Product Pipeline Into Clinical Development
Press Release
Data from Vaxin’s First Flu Vaccine Clinical Trial Reported in Journal “Vaccine” -Jan. 11, 2005
Link to whole article
Revolutionary Flu Vaccine in Development by Vaxin Inc.-Oct. 11, 2004
Link to whole article
Crucell And Vaxin Announce PER.C6 Licensing Agreement-Sept. 13, 2004
Link to whole article
Crucell Announces PER.C6(R) Licensing Agreement with Vaxin for Adenoviral Vaccine-Sept. 13, 204 /font>
Link to whole article
Key Patent Issued on Vaxin's Platform Technology - March 18, 2002
Link to entire press release
Anthrax Target of Vaxin’s Vaccine Research - October 1, 2001
Link to entire press release
Navy Awards $3.5 Million to Develop Needleless Vaccination - September 14, 2001
Link to entire press release
Vaxin Receives Grant For Tetanus Vaccine Patch Development - June 18, 2001
Link to entire press release
Vaxin Wins Navy Grant to Develop Vaccine for Dengue Fever - June 11, 2001
Link to entire press release
Inventor Is Proving No Pain Is Everyone's Gain, Receives International Coulter Award
- October 11, 2000
Link to entire press release
|
